← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2009Last known activity
Mar 1, 2019
Timeline
Drugs by trial phase (23 distinct, 14 trials)
Phase 4 (6 own, 0 via acquisition)
Phase 3 (9 own, 0 via acquisition)
Phase 2 (7 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Marketed drugs (2)
Recent trials (14)
- NCT03811418Lead sponsorPhase 3Mar 1, 2019
- NCT03462251Lead sponsorPhase 3May 24, 2018
- NCT02894398Lead sponsorPhase 2Sep 1, 2016
- NCT02404844CollaboratorPhase 2Dec 1, 2014
- NCT02248571Lead sponsorPhase 4Aug 1, 2014
- NCT01521715Lead sponsorPhase 4Jan 24, 2012
- NCT01520103CollaboratorPhase 2Jan 1, 2012
- NCT01553032CollaboratorPhase 4May 1, 2011
- NCT01266837Lead sponsorPhase 4Mar 1, 2011
- NCT01238029CollaboratorPhase 1Oct 1, 2010
- NCT01320111CollaboratorPhase 2Jul 1, 2010
- NCT00950820CollaboratorPhase 2Sep 1, 2009
- NCT00868634Lead sponsorPhase 3Feb 1, 2009
- NCT00732914CollaboratorPhase 3Jan 1, 2009
Details
- Founded
- Freiburg, DE Jun 1, 1996
- Last known activity
- Mar 1, 2019